Investing.com - Financial Markets Worldwide
Open in App

Susmed Inc (4263)

Tokyo
Currency in JPY
426.00
+19.00(+4.67%)
Closed·

4263 Income Statement

Period Ending:
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
2025
30/06
2026
30/06
Total Revenues
aa.aaaa.aa316530342462497
Total Revenues Growth
aa.aaaa.aa+174.78%+67.72%-35.47%+35.09%+7.58%
Cost Of Revenues
aa.aaaa.aa118121218
Gross Profit
aa.aaaa.aa305522330450479
Gross Profit Growth
aa.aaaa.aa+187.74%+71.15%-36.78%+36.36%+6.44%
Gross Profit Margin %
aa.aaaa.aa96.52%98.49%96.49%97.4%96.38%
Other Operating Expenses, Total
aa.aaaa.aa535570695750809
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aa+21.87%+6.54%+21.93%+7.91%+7.87%
aa.aaaa.aa226176243273247
aa.aaaa.aa309394452477562
aa.aaaa.aa-----
Operating Income
aa.aaaa.aa-230-48-365-300-330
Operating Income Growth
aa.aaaa.aa+30.93%+79.13%-660.42%+17.81%-10%
EBIT Margin %
aa.aaaa.aa-72.78%-9.06%-106.73%-64.94%-66.4%
Net Interest Expenses
aa.aaaa.aa-----
Net Interest Expenses Growth
aa.aaaa.aa-----
Interest Expense, Total
aa.aaaa.aa-----
Interest And Investment Income
aa.aaaa.aa-----
Other Non Operating Expenses, Total
aa.aaaa.aa124854
EBT, Excl. Unusual Items
aa.aaaa.aa-218-44-357-295-326
Gain (Loss) On Sale Of Assets
aa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aa-15-51-2-53
EBT, Incl. Unusual Items
aa.aaaa.aa-233-49-356-297-379
EBT, Incl. Unusual Items Growth
aa.aaaa.aa+15.88%+78.97%-626.53%+16.57%-27.61%
EBT, Incl. Unusual Items Margin
aa.aaaa.aa-73.73%-9.25%-104.09%-64.29%-76.26%
Income Tax Expense
aa.aaaa.aa01113
Net Income to Company
aa.aaaa.aa-233-50-357-298-382
Minority Interest
aa.aaaa.aa-----
Net Income
aa.aaaa.aa-233-50-357-298-382
Net Income Growth
aa.aaaa.aa+15.88%+78.54%-614%+16.53%-28.19%
Net Income Margin %
aa.aaaa.aa-73.73%-9.43%-104.39%-64.5%-76.86%
Preferred Dividend and Other Adjustments
aa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aa-233-50-357-298-382
Basic EPS - Continuing Operations
aa.aaaa.aa-15.87-3.05-21.39-17.75-22.67
Basic EPS - Continuing Operations Growth
aa.aaaa.aa+26.7%+80.79%-601.57%+17.02%-27.77%
Diluted EPS - Continuing Operations
aa.aaaa.aa-15.87-3.05-21.39-17.75-22.67
Diluted EPS - Continuing Operations Growth
aa.aaaa.aa+26.7%+80.79%-601.57%+17.02%-27.77%
Basic Weighted Average Shares Outstanding
aa.aaaa.aa14.6816.416.6916.7916.85
Diluted Weighted Average Shares Outstanding
aa.aaaa.aa14.6816.416.6916.7916.85
Dividend Per Share
aa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aa-----
EBITDA
aa.aaaa.aa-228-43-360-293-320
EBITDA Growth
aa.aaaa.aa-+81.14%-737.21%+18.61%-9.22%
EBITDA Margin %
aa.aaaa.aa-72.15%-8.11%-105.26%-63.42%-64.39%
EBIT
aa.aaaa.aa-230-48-365-300-330
* In Millions of JPY (except for per share items)

FAQ

What was Susmed’s revenue at year end?

At the end of the last reported fiscal year, Susmed (4263) recorded total revenue of 497.00 million JPY.

How much revenue did Susmed report in the most recent quarter?

In its most recent quarterly earnings report, Susmed posted revenue of 267.00 million JPY.

What was Susmed’s net income for the year?

For the full year, Susmed reported net income of -382.00 million JPY.

How much net income did Susmed post in the last quarter?

In the most recent quarter, Susmed (4263) posted net income of -50.00 million JPY.

What was Susmed’s gross profit for the year?

Gross profit for the year was reported at 479.00 million JPY.

How much gross profit did Susmed generate last quarter?

Susmed recorded gross profit of 261.00 million JPY in its latest quarterly report.

What was Susmed’s annual operating income?

For the full year, Susmed (4263) reported operating income of -330.00 million JPY.

What was Susmed’s operating income last quarter?

Quarterly operating income was 15.00 million JPY.

What was Susmed’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 17.50 million JPY.

What was the quarter-over-quarter change in EBITDA for Susmed?

EBITDA changed by 130.57% million JPY compared to the last quarter.

What is Susmed’s most recent gross profit margin?

The latest reported gross profit margin for Susmed (4263) is 97.75% million JPY.

What is Susmed’s most recent net income margin?

Net income margin based on recent financials is -18.73% million JPY.

What is Susmed’s most recent EBIT margin?

Susmed reported an EBIT margin of 5.62% million JPY based on current figures.

How did Susmed’s revenue change compared to the previous quarter?

Revenue changed by 92.09% million JPY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Susmed?

In the latest quarter, gross profit changed by 91.91% million JPY from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.